Drawing for CROSSOVER

USPTO serial 79053894

CROSSOVER

Reviewed by CopyMark Law Group

Reg. 3763289Status 404
Filing date
Status date
Registration date
Mar 23, 2010
Examiner
HAMMEL, LAURA A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CROSSOVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Purvi J. Patel

PURVI J PATEL HAYNES AND BOONE LLP2323 VICTORY AVENUEDALLAS, TX 75219-7673UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Compilation of statistics on analytical bases in medical, clinical, biotechnology and pharmaceutical research; business information management services, namely, collection and collation of medical, clinical, biotechnology and pharmaceutical data on a central file; database management, namely, collection and collation of information in a data baseSECTION 71 - CANCELLED—
041Training in medical, clinical, biotechnology and pharmaceutical researchSECTION 71 - CANCELLED—
042Clinical medical and pharmaceutical research, medical and scientific research in the nature of conducting clinical trials; epidemiological investigations in the nature of scientific research; research and development in the pharmaceutical and biotechnology fields; consultancy in the fields of medical research and medical technical writing, clinical scientific research, medical research, and pharmaceutical research, clinical product development, clinical trials, pharmaceutical research and development, and in biotechnology research and development; scientific analysis of statistics in medical, clinical, biotechnology and pharmaceutical research; consultancy in quality control for product safety in medical, clinical, biotechnology and pharmaceutical research; software development and computer programming of medical, clinical, pharmaceutical and biotechnology data banksSECTION 71 - CANCELLED—
045Legal services; legal services, namely, counseling related to product safety in the medical, clinical, pharmaceutical and biotechnology fieldsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 20, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Sep 20, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 28, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 3, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 3, 2017INPCINVALIDATION PROCESSED—
Jun 28, 2017INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 28, 2016C71TCANCELLED SECTION 71—
Apr 21, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 6, 2011TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 6, 2011CANTCANCELLATION TERMINATED NO. 999999—
Apr 6, 2011CANDCANCELLATION DENIED NO. 999999—
Feb 24, 2011PETCCANCELLATION INSTITUTED NO. 999999—
Jul 8, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 8, 2010FIMPFINAL DISPOSITION PROCESSED—
Jun 23, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 23, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2010ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 4, 2009OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 19, 2009OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 19, 2009OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 3, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 4, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2009NPUBNOTICE OF PUBLICATION—
Jul 1, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 1, 2009ALIEASSIGNED TO LIE—
Jun 24, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Jun 24, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 24, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 24, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 27, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 27, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 27, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 18, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 1, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 1, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 1, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 20, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 20, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 18, 2008RFNTREFUSAL PROCESSED BY IB—
Jun 23, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 23, 2008RFRRREFUSAL PROCESSED BY MPU—
Jun 23, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 22, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 20, 2008DOCKASSIGNED TO EXAMINER—
Jun 20, 2008NWAPNEW APPLICATION ENTERED—
Jun 19, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance